Approach to hematopoietic cell transplant candidates with respiratory viral detection

The management of respiratory viruses prior to hematopoietic cell transplant (HCT) can be controversial and requires special consideration of host factors, transplant parameters, and the specific respiratory virus (RV). In the setting of adenovirus (ADV), human metapneumovirus (HMPV), influenza, par...

Full description

Bibliographic Details
Main Authors: Sara R. Kim, Alpana Waghmare, Diego R. Hijano
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1339239/full
_version_ 1827379566725824512
author Sara R. Kim
Sara R. Kim
Alpana Waghmare
Alpana Waghmare
Alpana Waghmare
Diego R. Hijano
Diego R. Hijano
author_facet Sara R. Kim
Sara R. Kim
Alpana Waghmare
Alpana Waghmare
Alpana Waghmare
Diego R. Hijano
Diego R. Hijano
author_sort Sara R. Kim
collection DOAJ
description The management of respiratory viruses prior to hematopoietic cell transplant (HCT) can be controversial and requires special consideration of host factors, transplant parameters, and the specific respiratory virus (RV). In the setting of adenovirus (ADV), human metapneumovirus (HMPV), influenza, parainfluenza virus (PIV), and respiratory syncytial virus (RSV) detection prior to hematopoietic cell transplant (HCT), clinical practice guidelines recommend transplant delay when possible; however, there is much more ambiguity when other respiratory viruses, such as seasonal coronaviruses (CoVs), human rhinovirus (HRV), and SARS-CoV-2, are detected. Our aims for this review include detailing clinical practical guidelines and reviewing current literature on pre-transplant respiratory viral infections (RVIs), including antiviral therapies and prevention strategies, when available. We will center our discussion on three representative clinical scenarios, with the goal of providing practical guidance to clinicians.
first_indexed 2024-03-08T13:18:47Z
format Article
id doaj.art-a3c12addee034a928f3c42c48b546e25
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-03-08T13:18:47Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-a3c12addee034a928f3c42c48b546e252024-01-18T04:27:15ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602024-01-011110.3389/fped.2023.13392391339239Approach to hematopoietic cell transplant candidates with respiratory viral detectionSara R. Kim0Sara R. Kim1Alpana Waghmare2Alpana Waghmare3Alpana Waghmare4Diego R. Hijano5Diego R. Hijano6Division of Pediatric Infectious Diseases, Seattle Children’s Hospital, Seattle, WA, United StatesDepartment of Pediatrics, University of Washington, Seattle, WA, United StatesDivision of Pediatric Infectious Diseases, Seattle Children’s Hospital, Seattle, WA, United StatesDepartment of Pediatrics, University of Washington, Seattle, WA, United StatesVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, United StatesDepartments of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, TN, United StatesDepartment of Pediatrics, University of Tennessee Health Sciences Center, Memphis, TN, United StatesThe management of respiratory viruses prior to hematopoietic cell transplant (HCT) can be controversial and requires special consideration of host factors, transplant parameters, and the specific respiratory virus (RV). In the setting of adenovirus (ADV), human metapneumovirus (HMPV), influenza, parainfluenza virus (PIV), and respiratory syncytial virus (RSV) detection prior to hematopoietic cell transplant (HCT), clinical practice guidelines recommend transplant delay when possible; however, there is much more ambiguity when other respiratory viruses, such as seasonal coronaviruses (CoVs), human rhinovirus (HRV), and SARS-CoV-2, are detected. Our aims for this review include detailing clinical practical guidelines and reviewing current literature on pre-transplant respiratory viral infections (RVIs), including antiviral therapies and prevention strategies, when available. We will center our discussion on three representative clinical scenarios, with the goal of providing practical guidance to clinicians.https://www.frontiersin.org/articles/10.3389/fped.2023.1339239/fullrespiratory viruschildrenimmunocompromisedcancerhematopoietic cell transplant
spellingShingle Sara R. Kim
Sara R. Kim
Alpana Waghmare
Alpana Waghmare
Alpana Waghmare
Diego R. Hijano
Diego R. Hijano
Approach to hematopoietic cell transplant candidates with respiratory viral detection
Frontiers in Pediatrics
respiratory virus
children
immunocompromised
cancer
hematopoietic cell transplant
title Approach to hematopoietic cell transplant candidates with respiratory viral detection
title_full Approach to hematopoietic cell transplant candidates with respiratory viral detection
title_fullStr Approach to hematopoietic cell transplant candidates with respiratory viral detection
title_full_unstemmed Approach to hematopoietic cell transplant candidates with respiratory viral detection
title_short Approach to hematopoietic cell transplant candidates with respiratory viral detection
title_sort approach to hematopoietic cell transplant candidates with respiratory viral detection
topic respiratory virus
children
immunocompromised
cancer
hematopoietic cell transplant
url https://www.frontiersin.org/articles/10.3389/fped.2023.1339239/full
work_keys_str_mv AT sararkim approachtohematopoieticcelltransplantcandidateswithrespiratoryviraldetection
AT sararkim approachtohematopoieticcelltransplantcandidateswithrespiratoryviraldetection
AT alpanawaghmare approachtohematopoieticcelltransplantcandidateswithrespiratoryviraldetection
AT alpanawaghmare approachtohematopoieticcelltransplantcandidateswithrespiratoryviraldetection
AT alpanawaghmare approachtohematopoieticcelltransplantcandidateswithrespiratoryviraldetection
AT diegorhijano approachtohematopoieticcelltransplantcandidateswithrespiratoryviraldetection
AT diegorhijano approachtohematopoieticcelltransplantcandidateswithrespiratoryviraldetection